Recent News

• 03.26.2026 - Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
• 03.02.2026 - Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities
• 02.26.2026 - Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results
• 12.18.2025 - Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives
• 10.16.2025 - Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets
• 08.06.2025 - Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets

Recent Filings

• 03.02.2026 - 8-K Current report
• 03.02.2026 - EX-99.1 EX-99.1
• 02.26.2026 - 8-K Current report
• 02.26.2026 - EX-99.1 EX-99.1
• 02.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 12.18.2025 - 8-K Current report
• 12.18.2025 - EX-99.1 EX-99.1
• 10.16.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.16.2025 - EX-99.1 EX-99.1
• 10.16.2025 - 8-K Current report